Home › Companies › AURINIA PHARMACEUTICALS INC. › 2024-2025
Compiled from SEC Form N-PX filings and AURINIA PHARMACEUTICALS INC.’s Form 8-K, filed May 15, 2025 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of May 15, 2025: 9 items on AURINIA PHARMACEUTICALS INC.’s Form 8-K, filed May 15, 2025: 3 approved · 6 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore AURINIA PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are AURINIA PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 15, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Mr. Kevin Tang | 66,060,648 | -- | -- | 10,860,057 | 16,871,274 | 86% | Not verified | — |
| Elect Director: Mr. Jeffrey A. Bailey | 58,403,787 | -- | -- | 18,516,917 | 16,871,275 | 76% | Not verified | — |
| Elect Director: Ms. Kathy L. Goetz | 61,844,787 | -- | -- | 15,075,919 | 16,871,273 | 80% | Not verified | — |
| Elect Director: Mr. Peter Greenleaf | 59,168,775 | -- | -- | 17,751,929 | 16,871,275 | 77% | Not verified | — |
| Elect Director: Mr. Craig Johnson | 61,670,962 | -- | -- | 15,249,743 | 16,871,274 | 80% | Not verified | — |
| Elect Director: Ms. Tina S. Nova | 60,967,841 | -- | -- | 15,952,864 | 16,871,274 | 79% | Not verified | — |
| Proposal 2: Based upon the following votes, the shareholders approved the appointment of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Company's independent registered public accounting firm until the annual general meeting of sharehol | 88,332,423 | -- | -- | 5,459,552 | 4 | 94% | Approved | — |
| Proposal 3: Based upon the following votes, the shareholders approved, on a non-binding advisory basis, a "say on pay" resolution regarding the Company's executive compensation. | 58,851,313 | 17,180,345 | 889,047 | -- | 16,871,274 | 77% | Approved | — |
| Proposal 4: Based upon the following votes, the shareholders approved the Company's Amendment to the Equity Incentive Plan. | 48,215,063 | 28,374,579 | 331,064 | -- | 16,871,273 | 63% | Approved | — |
Source: AURINIA PHARMACEUTICALS INC., Form 8-K, filed with the SEC on May 15, 2025 — read the filing on EDGAR.
Each item below shows how the 187 asset managers that disclosed a AURINIA PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of AURINIA PHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 4 wordings of this item as funds reported it.
86% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Kevin Tang
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Mr. Kevin Tang”): 66,060,648 for, 10,860,057 withheld, per its Form 8-K filed May 15, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 86% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 49 asset managers below reported 12,343,209 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 3,793,638 | 0 | 0 | 0 | For |
| Vanguard | 1,876,102 | 0 | 0 | 0 | For |
| TIAA | 1,239,220 | 0 | 0 | 0 | For |
| Fidelity | 1,219,684 | 0 | 0 | 0 | For |
| Charles Schwab | 524,828 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 357,000 | 0 | 0 | 0 | For |
| Equitable | 344,853 | 0 | 0 | 0 | For |
| Goldman Sachs | 283,614 | 0 | 0 | 0 | For |
| JPMorgan | 244,999 | 0 | 0 | 0 | For |
| American Century | 238,445 | 0 | 0 | 0 | For |
| State Street | 236,765 | 0 | 0 | 0 | For |
| Lincoln Financial | 171,368 | 0 | 0 | 0 | For |
| Nationwide | 165,821 | 0 | 0 | 0 | For |
| UNIFIED SERIES TRUST | 130,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 124,694 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 106,494 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 98,822 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 95,857 | 0 | 0 | 0 | For |
| Brighthouse | 90,967 | 0 | 0 | 0 | For |
| Lazard | 89,783 | 0 | 0 | 0 | For |
| Northern Trust | 89,541 | 0 | 0 | 0 | For |
| Global X | 78,315 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 70,612 | 0 | 0 | 0 | For |
| Voya | 69,687 | 0 | 0 | 0 | For |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.
Combines 4 wordings of this item as funds reported it.
80% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Craig Johnson
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Mr. Craig Johnson”): 61,670,962 for, 15,249,743 withheld, per its Form 8-K filed May 15, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 80% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 48 asset managers below reported 11,986,209 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 3,793,638 | 0 | 0 | 0 | For |
| Vanguard | 1,876,102 | 0 | 0 | 0 | For |
| TIAA | 1,239,220 | 0 | 0 | 0 | For |
| Fidelity | 1,219,684 | 0 | 0 | 0 | For |
| Charles Schwab | 524,828 | 0 | 0 | 0 | For |
| Equitable | 344,853 | 0 | 0 | 0 | For |
| Goldman Sachs | 283,614 | 0 | 0 | 0 | For |
| JPMorgan | 244,999 | 0 | 0 | 0 | For |
| American Century | 238,445 | 0 | 0 | 0 | For |
| State Street | 236,765 | 0 | 0 | 0 | For |
| Lincoln Financial | 171,368 | 0 | 0 | 0 | For |
| Nationwide | 165,821 | 0 | 0 | 0 | For |
| UNIFIED SERIES TRUST | 130,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 124,694 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 106,494 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 98,822 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 95,857 | 0 | 0 | 0 | For |
| Brighthouse | 90,967 | 0 | 0 | 0 | For |
| Lazard | 89,783 | 0 | 0 | 0 | For |
| Northern Trust | 89,541 | 0 | 0 | 0 | For |
| Global X | 78,315 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 70,612 | 0 | 0 | 0 | For |
| Voya | 69,687 | 0 | 0 | 0 | For |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
| Invesco | 59,902 | 0 | 0 | 0 | For |
Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.
Combines 4 wordings of this item as funds reported it.
76% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Jeffrey A. Bailey
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Mr. Jeffrey A. Bailey”): 58,403,787 for, 18,516,917 withheld, per its Form 8-K filed May 15, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 76% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 48 asset managers below reported 11,629,853 for, 356,356 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 3,793,638 | 0 | 0 | 0 | For |
| Vanguard | 1,876,102 | 0 | 0 | 0 | For |
| TIAA | 1,239,220 | 0 | 0 | 0 | For |
| Fidelity | 1,219,684 | 0 | 0 | 0 | For |
| Charles Schwab | 524,828 | 0 | 0 | 0 | For |
| Equitable | 344,853 | 0 | 0 | 0 | For |
| Goldman Sachs | 283,614 | 0 | 0 | 0 | For |
| JPMorgan | 244,999 | 0 | 0 | 0 | For |
| American Century | 238,445 | 0 | 0 | 0 | For |
| State Street | 0 | 0 | 0 | 236,765 | Withhold |
| Lincoln Financial | 72,668 | 0 | 0 | 98,700 | Mixed |
| Nationwide | 165,821 | 0 | 0 | 0 | For |
| UNIFIED SERIES TRUST | 130,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 124,694 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 106,494 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 98,822 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 95,857 | 0 | 0 | 0 | For |
| Brighthouse | 90,967 | 0 | 0 | 0 | For |
| Lazard | 89,783 | 0 | 0 | 0 | For |
| Northern Trust | 89,541 | 0 | 0 | 0 | For |
| Global X | 78,315 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 70,612 | 0 | 0 | 0 | For |
| Voya | 69,687 | 0 | 0 | 0 | For |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
| Invesco | 59,902 | 0 | 0 | 0 | For |
Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.
Combines 5 wordings of this item as funds reported it.
80% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Kathy Goetz
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Ms. Kathy L. Goetz”): 61,844,787 for, 15,075,919 withheld, per its Form 8-K filed May 15, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 80% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 48 asset managers below reported 11,986,209 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 3,793,638 | 0 | 0 | 0 | For |
| Vanguard | 1,876,102 | 0 | 0 | 0 | For |
| TIAA | 1,239,220 | 0 | 0 | 0 | For |
| Fidelity | 1,219,684 | 0 | 0 | 0 | For |
| Charles Schwab | 524,828 | 0 | 0 | 0 | For |
| Equitable | 344,853 | 0 | 0 | 0 | For |
| Goldman Sachs | 283,614 | 0 | 0 | 0 | For |
| JPMorgan | 244,999 | 0 | 0 | 0 | For |
| American Century | 238,445 | 0 | 0 | 0 | For |
| State Street | 236,765 | 0 | 0 | 0 | For |
| Lincoln Financial | 171,368 | 0 | 0 | 0 | For |
| Nationwide | 165,821 | 0 | 0 | 0 | For |
| UNIFIED SERIES TRUST | 130,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 124,694 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 106,494 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 98,822 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 95,857 | 0 | 0 | 0 | For |
| Brighthouse | 90,967 | 0 | 0 | 0 | For |
| Lazard | 89,783 | 0 | 0 | 0 | For |
| Northern Trust | 89,541 | 0 | 0 | 0 | For |
| Global X | 78,315 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 70,612 | 0 | 0 | 0 | For |
| Voya | 69,687 | 0 | 0 | 0 | For |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
| Invesco | 59,902 | 0 | 0 | 0 | For |
Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.
Combines 4 wordings of this item as funds reported it.
77% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Peter Greenleaf
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Mr. Peter Greenleaf”): 59,168,775 for, 17,751,929 withheld, per its Form 8-K filed May 15, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 77% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 48 asset managers below reported 11,986,209 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 3,793,638 | 0 | 0 | 0 | For |
| Vanguard | 1,876,102 | 0 | 0 | 0 | For |
| TIAA | 1,239,220 | 0 | 0 | 0 | For |
| Fidelity | 1,219,684 | 0 | 0 | 0 | For |
| Charles Schwab | 524,828 | 0 | 0 | 0 | For |
| Equitable | 344,853 | 0 | 0 | 0 | For |
| Goldman Sachs | 283,614 | 0 | 0 | 0 | For |
| JPMorgan | 244,999 | 0 | 0 | 0 | For |
| American Century | 238,445 | 0 | 0 | 0 | For |
| State Street | 236,765 | 0 | 0 | 0 | For |
| Lincoln Financial | 171,368 | 0 | 0 | 0 | For |
| Nationwide | 165,821 | 0 | 0 | 0 | For |
| UNIFIED SERIES TRUST | 130,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 124,694 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 106,494 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 98,822 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 95,857 | 0 | 0 | 0 | For |
| Brighthouse | 90,967 | 0 | 0 | 0 | For |
| Lazard | 89,783 | 0 | 0 | 0 | For |
| Northern Trust | 89,541 | 0 | 0 | 0 | For |
| Global X | 78,315 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 70,612 | 0 | 0 | 0 | For |
| Voya | 69,687 | 0 | 0 | 0 | For |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
| Invesco | 59,902 | 0 | 0 | 0 | For |
Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.
Combines 4 wordings of this item as funds reported it.
79% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Tina S. Nova
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Ms. Tina S. Nova”): 60,967,841 for, 15,952,864 withheld, per its Form 8-K filed May 15, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 79% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 48 asset managers below reported 11,826,739 for, 159,470 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 3,793,638 | 0 | 0 | 0 | For |
| Vanguard | 1,876,102 | 0 | 0 | 0 | For |
| TIAA | 1,239,220 | 0 | 0 | 0 | For |
| Fidelity | 1,219,684 | 0 | 0 | 0 | For |
| Charles Schwab | 524,828 | 0 | 0 | 0 | For |
| Equitable | 344,853 | 0 | 0 | 0 | For |
| Goldman Sachs | 283,614 | 0 | 0 | 0 | For |
| JPMorgan | 244,999 | 0 | 0 | 0 | For |
| American Century | 238,445 | 0 | 0 | 0 | For |
| State Street | 236,765 | 0 | 0 | 0 | For |
| Lincoln Financial | 171,368 | 0 | 0 | 0 | For |
| Nationwide | 165,821 | 0 | 0 | 0 | For |
| UNIFIED SERIES TRUST | 130,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 124,694 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 106,494 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 98,822 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 95,857 | 0 | 0 | 0 | For |
| Brighthouse | 90,967 | 0 | 0 | 0 | For |
| Lazard | 0 | 0 | 0 | 89,783 | Withhold |
| Northern Trust | 89,541 | 0 | 0 | 0 | For |
| Global X | 78,315 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 70,612 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 0 | 69,687 | Withhold |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
| Invesco | 59,902 | 0 | 0 | 0 | For |
Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.
63% Approved · of votes cast
Description as filed by funds: Amendment to Equity Incentive Plan To approve the amendment to the Company's Equity Incentive Plan to increase the maximum number of common shares of the Company reserved for issuance pursuant to the Equity Incentive Plan, as set forth in the Company's Proxy Statement/Circular.
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Proposal 4: Based upon the following votes, the shareholders approved the Company's Amendment to the Equity Incentive Plan.”): 48,215,063 for, 28,374,579 against — passed, per its Form 8-K filed May 15, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 4: Based upon the following votes, the shareholders approved the Company's Amendment to the Equity Incentive Plan.”
Support: 63% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 31 asset managers below reported 6,500,850 for, 251,899 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,876,102 | 0 | 0 | 0 | For |
| TIAA | 1,239,220 | 0 | 0 | 0 | For |
| Fidelity | 1,219,684 | 0 | 0 | 0 | For |
| Equitable | 344,853 | 0 | 0 | 0 | For |
| Goldman Sachs | 283,614 | 0 | 0 | 0 | For |
| American Century | 0 | 238,445 | 0 | 0 | Against |
| State Street | 236,765 | 0 | 0 | 0 | For |
| Lincoln Financial | 171,368 | 0 | 0 | 0 | For |
| Nationwide | 159,707 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 124,694 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 106,494 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 98,822 | 0 | 0 | 0 | For |
| Brighthouse | 90,967 | 0 | 0 | 0 | For |
| Lazard | 89,783 | 0 | 0 | 0 | For |
| Northern Trust | 89,541 | 0 | 0 | 0 | For |
| Voya | 69,687 | 0 | 0 | 0 | For |
| Invesco | 59,902 | 0 | 0 | 0 | For |
| Pacific Life | 48,810 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 48,262 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 37,051 | 0 | 0 | 0 | For |
| ProShares | 31,437 | 0 | 0 | 0 | For |
| DWS | 20,916 | 0 | 0 | 0 | For |
| Legg Mason | 18,794 | 0 | 0 | 0 | For |
| Calvert | 0 | 13,454 | 0 | 0 | Against |
| AQR | 12,319 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.
Combines 3 wordings of this item as funds reported it.
63% Approved · of votes cast
Description as filed by funds: To approve the amendment to the Company's Equity Incentive Plan to increase the maximum number of common shares of the Company reserved for issuance pursuant to the Equity Incentive Plan, as set forth in the Company's Proxy Statement/Circular.
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Proposal 4: Based upon the following votes, the shareholders approved the Company's Amendment to the Equity Incentive Plan.”): 48,215,063 for, 28,374,579 against — passed, per its Form 8-K filed May 15, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 4: Based upon the following votes, the shareholders approved the Company's Amendment to the Equity Incentive Plan.”
Support: 63% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 19 asset managers below reported 5,164,184 for, 391,509 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 3,793,638 | 0 | 0 | 0 | For |
| Charles Schwab | 524,828 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 0 | 357,000 | 0 | 0 | Against |
| JPMorgan | 244,999 | 0 | 0 | 0 | For |
| UNIFIED SERIES TRUST | 130,000 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 95,857 | 0 | 0 | 0 | For |
| Global X | 78,315 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 36,103 | 34,509 | 0 | 0 | Mixed |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 45,900 | 0 | 0 | 0 | For |
| John Hancock | 45,791 | 0 | 0 | 0 | For |
| New York Life | 26,909 | 0 | 0 | 0 | For |
| SEI | 25,100 | 0 | 0 | 0 | For |
| Prudential/PGIM | 21,700 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 18,900 | 0 | 0 | 0 | For |
| Nationwide | 6,114 | 0 | 0 | 0 | For |
| WILSHIRE MUTUAL FUNDS INC | 2,910 | 0 | 0 | 0 | For |
| BRANDYWINE OAK PRIVATE WEALTH LLC | 500 | 0 | 0 | 0 | For |
| Principal | 282 | 0 | 0 | 0 | For |
Combines 10 wordings of this item as funds reported it.
77% Approved · of votes cast
Description as filed by funds: Advisory Resolution on Executive Compensation To approve, on a non-binding advisory basis, a "say on pay" resolution regarding the Company's executive compensation set forth in the Company's Proxy Statement/Circular.
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Proposal 3: Based upon the following votes, the shareholders approved, on a non-binding advisory basis, a "say on pay" resolution regarding the Company's executive compensation.”): 58,851,313 for, 17,180,345 against — passed, per its Form 8-K filed May 15, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3: Based upon the following votes, the shareholders approved, on a non-binding advisory basis, a "say on pay" resolution regarding the Company's executive compensation.”
Support: 77% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of AURINIA PHARMACEUTICALS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (6 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 3,793,638 | 0 | 0 | 0 | For |
| Vanguard | 1,876,102 | 0 | 0 | 0 | For |
| TIAA | 1,239,220 | 0 | 0 | 0 | For |
| Fidelity | 1,219,684 | 0 | 0 | 0 | For |
| Charles Schwab | 524,828 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 0 | 0 | 357,000 | 0 | Abstain |
| Equitable | 344,853 | 0 | 0 | 0 | For |
| Goldman Sachs | 283,614 | 0 | 0 | 0 | For |
| JPMorgan | 244,999 | 0 | 0 | 0 | For |
| American Century | 0 | 238,445 | 0 | 0 | Against |
| State Street | 236,765 | 0 | 0 | 0 | For |
| Lincoln Financial | 171,368 | 0 | 0 | 0 | For |
| Nationwide | 165,821 | 0 | 0 | 0 | For |
| UNIFIED SERIES TRUST | 130,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 124,694 | 0 | 0 | Against |
| AIG/SunAmerica | 106,494 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 98,822 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 95,857 | 0 | 0 | 0 | For |
| Brighthouse | 90,967 | 0 | 0 | 0 | For |
| Lazard | 89,783 | 0 | 0 | 0 | For |
| Northern Trust | 89,541 | 0 | 0 | 0 | For |
| Global X | 78,315 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 70,612 | 0 | 0 | 0 | For |
| Voya | 69,687 | 0 | 0 | 0 | For |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
Fund voting reports, all 48 managers: 11,527,901 for, 423,041 against, 357,000 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 10,029,500 | 0 | 0 | 0 | For |
| NEA Management Company, LLC | 3,969,834 | 0 | 0 | 0 | For |
| ARMISTICE CAPITAL, LLC | 3,062,840 | 0 | 0 | 0 | For |
| BlackRock | 2,136,707 | 0 | 0 | 0 | For |
| State Street | 2,008,708 | 0 | 0 | 0 | For |
| Nuveen | 1,245,549 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,200,783 | 0 | 0 | 0 | For |
| JUPITER ASSET MANAGEMENT LTD | 926,779 | 0 | 0 | 0 | For |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 861,284 | 0 | 0 | 0 | For |
| Northern Trust | 808,009 | 0 | 0 | 0 | For |
| Lazard | 631,211 | 0 | 0 | 0 | For |
| Charles Schwab | 524,828 | 0 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 513,441 | 0 | 0 | 0 | For |
| Woodline Partners LP | 427,239 | 0 | 0 | 0 | For |
| SEGALL BRYANT & HAMILL, LLC | 375,639 | 0 | 0 | 0 | For |
| Goldman Sachs | 372,908 | 0 | 0 | 0 | For |
| Renaissance | 313,423 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 279,436 | 0 | 0 | 0 | For |
| RBC Capital Markets, LLC | 266,498 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 246,179 | 0 | 0 | 0 | For |
| American Century | 0 | 238,856 | 0 | 0 | Against |
| AQR | 229,720 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 229,172 | 0 | 0 | 0 | For |
| Vanguard | 220,737 | 0 | 0 | 0 | For |
| Prudential/PGIM | 158,900 | 0 | 0 | 0 | For |
Institutional-manager reports, all 154 managers: 32,987,016 for, 758,624 against, 1,000 abstained, 2,047 not voted. Showing the 25 largest; see all in the interactive database.
Combines 3 wordings of this item as funds reported it.
94% Approved · of votes cast
Description as filed by funds: Appointment of Auditors Appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm until the close of the 2026 annual general meeting of shareholders or until a successor is appointed.
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Proposal 2: Based upon the following votes, the shareholders approved the appointment of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Company's independent registered public accounting firm unti”): 88,332,423 for, 5,459,552 withheld — passed, per its Form 8-K filed May 15, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2: Based upon the following votes, the shareholders approved the appointment of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Company's independent registered public accounting firm until the annual general meeting of shareholders to be held in 2026 or until a succ…”
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 49 asset managers below reported 12,308,442 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 3,793,638 | 0 | 0 | 0 | For |
| Vanguard | 1,876,102 | 0 | 0 | 0 | For |
| TIAA | 1,239,220 | 0 | 0 | 0 | For |
| Fidelity | 1,219,684 | 0 | 0 | 0 | For |
| Charles Schwab | 524,828 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 357,000 | 0 | 0 | 0 | For |
| Equitable | 344,853 | 0 | 0 | 0 | For |
| Goldman Sachs | 283,614 | 0 | 0 | 0 | For |
| JPMorgan | 244,999 | 0 | 0 | 0 | For |
| American Century | 238,445 | 0 | 0 | 0 | For |
| State Street | 236,765 | 0 | 0 | 0 | For |
| Lincoln Financial | 171,368 | 0 | 0 | 0 | For |
| Nationwide | 165,821 | 0 | 0 | 0 | For |
| UNIFIED SERIES TRUST | 130,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 124,694 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 106,494 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 98,822 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 95,857 | 0 | 0 | 0 | For |
| Brighthouse | 90,967 | 0 | 0 | 0 | For |
| Lazard | 89,783 | 0 | 0 | 0 | For |
| Northern Trust | 89,541 | 0 | 0 | 0 | For |
| Global X | 78,315 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 70,612 | 0 | 0 | 0 | For |
| Voya | 69,687 | 0 | 0 | 0 | For |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 137,747,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 2.75% |
| 2 | Vanguard | 1.36% |
| 3 | TIAA | 0.90% |
| 4 | Fidelity | 0.89% |
| 5 | Charles Schwab | 0.38% |
| 6 | HUSSMAN INVESTMENT TRUST | 0.26% |
| 7 | Equitable | 0.25% |
| 8 | Goldman Sachs | 0.21% |
| 9 | JPMorgan | 0.18% |
| 10 | American Century | 0.17% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | TANG CAPITAL MANAGEMENT LLC | 7.28% |
| 2 | NEA Management Company, LLC | 2.88% |
| 3 | ARMISTICE CAPITAL, LLC | 2.22% |
| 4 | BlackRock | 1.55% |
| 5 | State Street | 1.46% |
| 6 | Nuveen | 0.90% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 0.87% |
| 8 | JUPITER ASSET MANAGEMENT LTD | 0.67% |
| 9 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.63% |
| 10 | Northern Trust | 0.59% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 9.47% | 13D |
| BlackRock | 6.36% | 13F |
| Chin Kyu Huh | 4.74% | 13D |
| State Street | 2.07% | 13F |
| Morgan Stanley | 1.72% | 13F |
| Vanguard Group | 1.43% | 13F |
| Geode Capital | 1.26% | 13F |
| Goldman Sachs | 1.18% | 13F |
| Nuveen | 1.08% | 13F |
| Northern Trust | 0.75% | 13F |
Percentages above are of 137,747,000 shares outstanding, as reported by AURINIA PHARMACEUTICALS INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from AURINIA PHARMACEUTICALS INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At AURINIA PHARMACEUTICALS INC.'s shareholder meeting held May 15, 2025, in the 2024-2025 proxy season, 187 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,447 separate fund positions. Their filings are grouped here into 10 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Advisory Resolution on Executive Compensation To approve, on a non-binding advisory basis, a… — AURINIA PHARMACEUTICALS INC.'s filing reports the proposal as approved, with 77% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: AURINIA PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 15, 2025.
AURINIA PHARMACEUTICALS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.